par Klastersky, Jean 
;Awada, Ahmad ;Paesmans, Marianne ;Aoun, Michel
Référence Critical reviews in oncology/hematology, 78, page (185-194)
Publication Publié, 2011
;Awada, Ahmad ;Paesmans, Marianne ;Aoun, Michel Référence Critical reviews in oncology/hematology, 78, page (185-194)
Publication Publié, 2011
Article révisé par les pairs
| Résumé : | The present state of the art for management of patients with febrile neutropenia has been reviewed as well as potential ways to improve it in the future. A major advance has been the possibility to predict, accurately and early, the risk of complications and death in those patients. While the algorithm for therapy in low-risk patients is presently straightforward, significant progresses are needed for patients who are at higher risk of presenting severe complications. © 2010 Elsevier Ireland Ltd. |
